Found: 3
Select item for more details and to access through your institution.
Letter: should anti-viral therapy be recommended for individuals chronically infected with hepatitis B virus and at low risk of hepatocellular carcinoma?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 1, p. 181, doi. 10.1111/apt.13814
- By:
- Publication type:
- Article
Letter: cytokeratin-18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 1, p. 183, doi. 10.1111/apt.13820
- By:
- Publication type:
- Article
Letter: which patients with hepatitis B virus-related hepatocellular carcinoma should receive nucleos(t)ide analogue therapy?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2016, v. 44, n. 8, p. 908, doi. 10.1111/apt.13773
- By:
- Publication type:
- Article